Please login to the form below

Not currently logged in
Email:
Password:

injectables

This page shows the latest injectables news and features for those working in and with pharma, biotech and healthcare.

Pfizer builds gap between pharma and consumer health units

Pfizer builds gap between pharma and consumer health units

There are other changes afoot as well. Innovative health is rebadged as innovative medicines and will absorb biosimilar drugs and sterile injectables – currently part of Pfizer’s essential health division spanning ... The sterile injectables unit

Latest news

More from news
Approximately 3 fully matching, plus 388 partially matching documents found.

Latest Intelligence

  • The sound of silence puts the squeeze on generics and biosimilars The sound of silence puts the squeeze on generics and biosimilars

    The issues that need urgent discussion are sectors with 100% generic penetration, such as hospital injectables and oncology products where there is no growth, yet companies have to contend with rising

  • Deal Watch - May 2017 Deal Watch - May 2017

    The acquisition of Akorn, a US based company that manufactures “alternate”formulations such as liquids, gels and injectables  and markets a range of products with a focus on ophthalmology will cost ... Fresenius will pay Merck a single digit

  • Deal Watch March 2017 Deal Watch March 2017

    Sihuan Pharmaceuticals, a leader in China’s cardio-cerebrovascular area, has acquired the manufacturer Ambest Pharmaceuticals, with its portfolio of injectable products, for $160m. ... 190. Ambest Pharmaceutical. Sihuan Pharmaceutical. Acquisition.

  • Deal Watch November 2016 Deal Watch November 2016

    The company has manufacturing facilities covering APIs and a wide variety of dosage forms ranging from injectables to tablets, creams and gels. ... Eagle's current focus is on the development of novel, optimised formulations of FDA-approved injectable

  • Deal Watch October 2016 Deal Watch October 2016

    So when Janssen announced this month it had divested five injectable pain products to Piramal for $175m, it is assumed this was a consequence of low margins and manufacturing issues. ... 200+. Janssen / J&J (US). Piramal (IN). Asset acquisition. 5

More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics